Vyant Bio Ownership 2024 | Who Owns Vyant Bio Now?

OverviewChart

Institutional Ownership

5.78%

Insider Ownership

18.78%

Retail Ownership

75.44%

Institutional Holders

22.00

Vyant Bio Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.81%	-	47,256	-98,463	-67.57%	27,408,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.66%	-	38,820	-	-	22,515,000	Mar 31, 2023
MAYO CLINIC	0.47%	0.01%	27,742	-	-	16,090,000	Mar 31, 2023
BLACKROCK INC.	0.45%	-	26,558	-	-	15,404,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.38%	-	22,419	22,419	100.00%	13,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	-	20,001	20,001	100.00%	11,601,000	Mar 31, 2023
STATE STREET CORP	0.26%	-	15,038	-	-	8,722,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.24%	-	13,820	-500	-3.49%	8,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.21%	0.00%	12,521	953	8.24%	7,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	5,463	508	10.25%	3,169,000	Mar 31, 2023
US BANCORP \DE\	0.08%	-	4,962	-	-	2,878,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	2,478	2,478	100.00%	1,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	31	1	3.33%	18,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	24	24	100.00%	14,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	9	-324	-97.30%	5,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-11,224	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-16,911	-100.00%	-	Mar 31, 2023
FMR LLC	-	-	-	-3	-100.00%	-	Mar 31, 2023

Vyant Bio's largest institutional shareholder is VANGUARD GROUP INC, holding 0.81% of the company's total share outstanding, currently valued at $27.41M. The top 10 institutional shareholders own together 3.91% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MAYO CLINIC	0.47%	0.01%	27,742	-	-	16,090,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.21%	0.00%	12,521	953	8.24%	7,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	2,478	2,478	100.00%	1,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.24%	-	13,820	-500	-3.49%	8,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.38%	-	22,419	22,419	100.00%	13,000	Mar 31, 2023
US BANCORP \DE\	0.08%	-	4,962	-	-	2,878,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.66%	-	38,820	-	-	22,515,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	-	20,001	20,001	100.00%	11,601,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	5,463	508	10.25%	3,169,000	Mar 31, 2023
VANGUARD GROUP INC	0.81%	-	47,256	-98,463	-67.57%	27,408,000	Mar 31, 2023
STATE STREET CORP	0.26%	-	15,038	-	-	8,722,000	Mar 31, 2023
BLACKROCK INC.	0.45%	-	26,558	-	-	15,404,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	24	24	100.00%	14,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	31	1	3.33%	18,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	9	-324	-97.30%	5,000	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-16,911	-100.00%	-	Mar 31, 2023
FMR LLC	-	-	-	-3	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-11,224	-100.00%	-	Mar 31, 2023

The largest Vyant Bio shareholder by % of total assets is MAYO CLINIC. The company owns 27.74K shares of Vyant Bio (VYNT), representing 0.01% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	0.38%	-	22,419	22,419	100.00%	13,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	-	20,001	20,001	100.00%	11,601,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	2,478	2,478	100.00%	1,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.21%	0.00%	12,521	953	8.24%	7,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	5,463	508	10.25%	3,169,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	24	24	100.00%	14,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	31	1	3.33%	18,000	Mar 31, 2023
BLACKROCK INC.	0.45%	-	26,558	-	-	15,404,000	Mar 31, 2023
STATE STREET CORP	0.26%	-	15,038	-	-	8,722,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.66%	-	38,820	-	-	22,515,000	Mar 31, 2023
US BANCORP \DE\	0.08%	-	4,962	-	-	2,878,000	Mar 31, 2023
MAYO CLINIC	0.47%	0.01%	27,742	-	-	16,090,000	Mar 31, 2023
FMR LLC	-	-	-	-3	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.00%	-	9	-324	-97.30%	5,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.24%	-	13,820	-500	-3.49%	8,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-11,224	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-16,911	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	0.81%	-	47,256	-98,463	-67.57%	27,408,000	Mar 31, 2023

As of Mar 31 2023, Vyant Bio's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 22.42K stocks of VYNT, valued at $13.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.81%	-	47,256	-98,463	-67.57%	27,408,000	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-16,911	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-11,224	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.24%	-	13,820	-500	-3.49%	8,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	9	-324	-97.30%	5,000	Mar 31, 2023
FMR LLC	-	-	-	-3	-100.00%	-	Mar 31, 2023
MAYO CLINIC	0.47%	0.01%	27,742	-	-	16,090,000	Mar 31, 2023
US BANCORP \DE\	0.08%	-	4,962	-	-	2,878,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.66%	-	38,820	-	-	22,515,000	Mar 31, 2023
STATE STREET CORP	0.26%	-	15,038	-	-	8,722,000	Mar 31, 2023
BLACKROCK INC.	0.45%	-	26,558	-	-	15,404,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	31	1	3.33%	18,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	24	24	100.00%	14,000	Mar 31, 2023
UBS GROUP AG	0.09%	-	5,463	508	10.25%	3,169,000	Mar 31, 2023
VIRTU FINANCIAL LLC	0.21%	0.00%	12,521	953	8.24%	7,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	2,478	2,478	100.00%	1,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	-	20,001	20,001	100.00%	11,601,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	0.38%	-	22,419	22,419	100.00%	13,000	Mar 31, 2023

As of Mar 31 2023, Vyant Bio's biggest institutional seller is VANGUARD GROUP INC. The company sold -98.46K shares of VYNT, valued at $27.41M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MILLENNIUM MANAGEMENT LLC	0.38%	-	22,419	22,419	100.00%	13,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.34%	-	20,001	20,001	100.00%	11,601,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.04%	-	2,478	2,478	100.00%	1,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	24	24	100.00%	14,000	Mar 31, 2023

Vyant Bio's largest new institutional shareholder by number of shares is MILLENNIUM MANAGEMENT LLC, purchased 22.42K shares, valued at $13.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	-	-	-	-16,911	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-11,224	-100.00%	-	Mar 31, 2023
FMR LLC	-	-	-	-3	-100.00%	-	Mar 31, 2023

Vyant Bio's largest sold out institutional shareholder by shares sold is HRT FINANCIAL LP, sold -16.91K shares, valued at -, as of undefined.

Vyant Bio Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	723,643	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	182,605	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	20,576	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	13,043	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	36,389	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	44,740	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,830	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	6,195	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	3,300	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	2,210	-	-	Mar 31, 2024

Vyant Bio's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 723.64K shares, compromising 0.00% of its total assets.

Vyant Bio Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	22	29.41%
30 Jun, 22	17	-15.00%
31 Mar, 22	20	-13.04%
31 Dec, 21	23	9.52%
30 Sep, 21	21	-22.22%
30 Jun, 21	27	80.00%
31 Mar, 21	15	-

As of 30 Sep 22, 22 institutions are holding Vyant Bio's shares, representing an increase of 29.41% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	1,700,508	5.01%
30 Jun, 22	1,619,321	-10.87%
31 Mar, 22	1,816,836	-21.46%
31 Dec, 21	2,313,313	2.36%
30 Sep, 21	2,260,070	0.48%
30 Jun, 21	2,249,352	247.35%
31 Mar, 21	647,569	-

Vyant Bio (VYNT) has 1.70M shares outstanding as of 30 Sep 22, up 5.01% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	5.78%	19.07%
30 Jun, 22	5.51%	14.04%
31 Mar, 22	6.26%	9.83%
31 Dec, 21	7.98%	13.13%
30 Sep, 21	7.80%	12.95%
30 Jun, 21	7.76%	155.48%
31 Mar, 21	2.23%	-

As of 30 Sep 22, Vyant Bio is held by 5.78% institutional shareholders, representing a 19.07% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	9	50.00%
30 Jun, 22	6	-14.29%
31 Mar, 22	7	-
31 Dec, 21	7	-
30 Sep, 21	7	-68.18%
30 Jun, 21	22	46.67%
31 Mar, 21	15	-

9 institutional shareholders have increased their position in VYNT stock as of 30 Sep 22 compared to 6 in the previous quarter (a 50.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	2	-33.33%
30 Jun, 22	3	-50.00%
31 Mar, 22	6	100.00%
31 Dec, 21	3	-
30 Sep, 21	3	200.00%
30 Jun, 21	1	-
31 Mar, 21	-	-

2 institutional shareholders have reduced their position in VYNT stock as of 30 Sep 22 compared to 3 in the previous quarter (a -33.33% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	22	29.41%	1,700,508	5.01%	5.78%	19.07%	9	50.00%	2	-33.33%
30 Jun, 22	17	-15.00%	1,619,321	-10.87%	5.51%	14.04%	6	-14.29%	3	-50.00%
31 Mar, 22	20	-13.04%	1,816,836	-21.46%	6.26%	9.83%	7	-	6	100.00%
31 Dec, 21	23	9.52%	2,313,313	2.36%	7.98%	13.13%	7	-	3	-
30 Sep, 21	21	-22.22%	2,260,070	0.48%	7.80%	12.95%	7	-68.18%	3	200.00%
30 Jun, 21	27	80.00%	2,249,352	247.35%	7.76%	155.48%	22	46.67%	1	-
31 Mar, 21	15	-	647,569	-	2.23%	-	15	-	-	-

Vyant Bio Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	99	$1.34	$132.67	14,685
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	666	$1.33	$888.44	14,019

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	99	$1.34	$132.67	14,685
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	666	$1.33	$888.44	14,019

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 27, 2023	Hansen Paul R.	director	-	W-Will	Buy	6,783	-	-	159,778
Jan 19, 2023	Hansen Paul R.	director	-	A-Award	Buy	4,032	-	-	152,995
Jan 19, 2023	Harris Geoffrey E.	director	-	A-Award	Buy	5,712	-	-	19,761
Jan 19, 2023	FLETCHER R JOHN	director	-	A-Award	Buy	4,368	-	-	23,895
Jan 19, 2023	Horobin Joanna	director	-	A-Award	Buy	7,526	-	-	23,123
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	99	$1.34	$132.67	14,685
Nov 22, 2022	Harris Geoffrey E.	director	-	S-Sale	Sell	666	$1.33	$888.44	14,019
Oct 19, 2022	Horobin Joanna	director	-	A-Award	Buy	14,285	-	-	77,994
Oct 19, 2022	Harris Geoffrey E.	director	-	A-Award	Buy	10,841	-	-	73,920
Oct 19, 2022	Hansen Paul R.	director	-	A-Award	Buy	7,653	-	-	744,826
Oct 19, 2022	FLETCHER R JOHN	director	-	A-Award	Buy	8,290	-	-	97,649
Jul 29, 2022	Horobin Joanna	director		A-Award	Buy	8,092	-	-	63,709
Jul 29, 2022	Horobin Joanna	director	-	A-Award	Buy	8,092	-	$0.81	63,709
Jul 29, 2022	Harris Geoffrey E.	director		A-Award	Buy	6,141	-	-	63,079
Jul 29, 2022	Harris Geoffrey E.	director	-	A-Award	Buy	6,141	-	$0.61	63,079
Jul 29, 2022	FLETCHER R JOHN	director		A-Award	Buy	4,696	-	-	89,359
Jul 29, 2022	FLETCHER R JOHN	director	-	A-Award	Buy	4,696	-	$0.47	89,359
Jul 29, 2022	Hansen Paul R.	director		A-Award	Buy	4,335	-	-	737,173
Apr 19, 2022	Horobin Joanna	director		A-Award	Buy	6,796	-	-	55,617
Apr 19, 2022	Horobin Joanna	director	-	A-Award	Buy	6,796	-	$0.68	55,617

The last insider sell of Vyant Bio's stock was made by Harris Geoffrey E. on Nov 22 2022, selling 99 shares at $1.34 per share (valued at $132.67).

Vyant Bio Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	4	-	-
Q4 2022	4	2	200.00%
Q3 2022	4	-	-
Q2 2022	5	-	-
Q1 2022	16	-	-
Q4 2021	9	-	-
Q3 2021	6	-	-
Q2 2021	12	5	240.00%
Q1 2021	32	-	-
Q1 2020	2	-	-
Q3 2019	5	-	-
Q1 2019	7	1	700.00%
Q4 2018	-	1	-
Q3 2018	1	-	-
Q2 2018	3	-	-
Q4 2017	2	1	200.00%
Q3 2017	18	1	1800.00%
Q2 2017	19	2	950.00%
Q1 2017	3	-	-
Q4 2016	18	1	1800.00%

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Vyant Bio's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	-	-
Q4 2022	-	2	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	7	-	-
Q3 2021	6	-	-
Q2 2021	10	-	-
Q1 2021	-	-	-
Q1 2020	-	-	-
Q3 2019	-	-	-
Q1 2019	7	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q4 2017	2	-	-
Q3 2017	4	-	-
Q2 2017	4	1	400.00%
Q1 2017	-	-	-
Q4 2016	4	1	400.00%

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Vyant Bio's stocks.

Vyant Bio Peer Ownership

Ticker	Company
DYAI	Dyadic International, Inc.
NTRB	Nutriband Inc.
ALGS	Aligos Therapeutics, Inc.
SABS	SAB Biotherapeutics, Inc.
LGVN	Longeveron Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
SRZN	Surrozen, Inc.
KA	Kineta, Inc.
VRAX	Virax Biolabs Group Limited
RNXT	RenovoRx, Inc.
RZLT	Rezolute, Inc.
INDP	Indaptus Therapeutics, Inc.
DMAC	DiaMedica Therapeutics Inc.
TPST	Tempest Therapeutics, Inc.
MOLN	Molecular Partners AG
FBRX	Forte Biosciences, Inc.
KTRA	Kintara Therapeutics, Inc.

VYNT Ownership FAQ

Who Owns Vyant Bio?

Vyant Bio is owned by institutional shareholders (5.78%), insiders (18.78%), and public (75.44%). The largest institutional shareholder of Vyant Bio is VANGUARD GROUP INC (0.81% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Vyant Bio?

Vyant Bio's major institutional shareholders are VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MAYO CLINIC, BLACKROCK INC., and MILLENNIUM MANAGEMENT LLC. The top five shareholders own together 2.77% of the company's share outstanding.

How many Vyant Bio shareholders are there?

As of Sep 2022, there are 22 institutional shareholders of Vyant Bio.

What percentage of Vyant Bio is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 47.26K shares of Vyant Bio, representing 0.81% of the company's total shares outstanding, valued at $27.41M (as of Mar 2023).

What percentage of Vyant Bio is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Mar 2023, GEODE CAPITAL MANAGEMENT, LLC holds 38.82K shares of Vyant Bio (VYNT), compromising 0.66% of the company, valued at $22.52M.

What percentage of Vyant Bio is owned by MAYO CLINIC?

MAYO CLINIC is the third largest holder of Vyant Bio. The company owns 27.74K of the company's shares outstanding (worth $16.09M).